Objectives: To identify factors contributing to delays in in the initiation of treatment among ST elevation myocardial infarction patients.
Methods: The prospective cohort study was conducted at the National Institute of Cardiovascular Disease, Karachi, from December 2020 to June 2021, and comprised ST elevation myocardial infarction patients of either gender aged at least 18 years. Time delay categories were 1st and 2nd delays that were patient-related, and 3rd delay that was system-related), with thresholds of ≤90 minutes and ≤120 minutes. Those who experienced delays were placed in group A, while the rest were in group B. Socio-demographic factors, co-morbidities, reasons of delay and in-hospital complications were recorded. Data was analysed using SPSS (version 21).
Results: Of the 348 patients, 174(50%) were in group A; 129(74.1%) males and 45(25.9%) females with overall mean age 57.52±10.59 years. The remaining 174(50%) were in group B; 148(85.1%) males and 26(14.9%) females with overall mean age 54.4±12.1 years. The delays were associated with male gender, education level and employment status (p<0.05). Factors contributing to 1st delay included lack of cardiac symptom awareness 77(77%), belief in symptom resolution 38(38%), attributing symptoms to gastric issues 30(30%), and dependency 14(14%). Transportation issues 4(66.7%), indirect commutation 3(50%) and distance 82(47.1%) caused the 2nd delay, while improper referrals 2(50%) and decision delays of more than an hour 1(25%) were common in the 3rd delay. Moreover, 150(86.2%) experienced in-hospital complications, and 88(50.6%) encountered both pre- and post-percutaneous coronary intervention complications (p=0.01).
Conclusions: Pre-hospital and post-hospital delaying factors had an impact on ST elevation myocardial infarction complications, highlighting the need for improved patient education on recognising cardiac symptoms and seeking timely medical attention to reduce ST elevation myocardial infarction complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.47391/JPMA.10722 | DOI Listing |
Int J Pediatr Otorhinolaryngol
January 2025
Otorhinolaryngology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt; Medicine and Surgery Program, Menoufia National University, Menoufia, Egypt. Electronic address:
Purpose: Familial Mediterranean fever (FMF) is the most prevalent genetic autoinflammatory disease worldwide. There are several novel advancements in pathophysiology, genetic testing, diagnosis, comorbidities, disease-related damage, and treatment strategies. This study aimed to assess the effect of tonsillectomy on FMF disease severity and activity.
View Article and Find Full Text PDFJMIR Ment Health
January 2025
Division of Psychology and Mental Health, University of Manchester, Manchester, United Kingdom.
Background: Digital mental health interventions (DMHIs) to monitor and improve the health of people with psychosis or bipolar disorder show promise; however, user engagement is variable, and integrated clinical use is low.
Objective: This prospectively registered systematic review examined barriers and facilitators of clinician and patient engagement with DMHIs, to inform implementation within real-world settings.
Methods: A systematic search of 7 databases identified empirical studies reporting qualitative or quantitative data about factors affecting staff or patient engagement with DMHIs aiming to monitor or improve the mental or physical health of people with psychosis or bipolar disorder.
Ann Intensive Care
January 2025
School of Medicine and Psychology, Australian National University, Canberra, Australia.
Background: There is scarce literature evaluating long term psychological or Quality of Life (QoL) outcomes in family members of ICU survivors, who have not experienced invasive ventilation. The objective was to compare long-term psychological symptoms and QoL outcomes in family members of intubated versus non-intubated ICU survivors and to evaluate dyadic relationships between paired family members and survivors.
Methods: Prospective, multicentre cohort study among four medical-surgical ICUs in Australia.
Int Ophthalmol
January 2025
Chairman and Professor of Ophthalmology, Kasr Alainy Faculty of Medicine, Cairo University, Giza, Egypt.
Purpose: This study evaluated the efficacy, safety, and tolerability of a single-dose, preservative-free (PF) Dorzolamide/Timolol combination (Twinzol-SDU).
Methods: A 3-month single-arm, multicenter, prospective cohort study was conducted in Egypt between January 2021 and October 2022 on previously diagnosed and controlled patients with ocular hypertension and/or glaucoma. Efficacy was assessed using the change in intraocular pressure (IOP) after 6 and 12 weeks.
Int Ophthalmol
January 2025
Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150, Kubang Kerian, Kelantan, Malaysia.
Purpose: To evaluate the effects of pre-operative ranibizumab injection on microvascular density (MVD), 8-hydroxyguanosine (8-OHdG) and recurrence after surgical excision of primary pterygium.
Method: This was a prospective cohort interventional study involving 52 patients with primary pterygium divided equally into control and intervention groups. The intervention group received 0.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!